iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Malignant Hyperthermia

Malignant Hyperthermia

Recognition and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 August 2025
Anaesthetics

Clinical Guidelines

Consensus guidelines on perioperative management of malignant hyperthermia
National
European Malignant Hyperthermia Group guidelines for the management of malignant hyperthermia
National
Malignant hyperthermia 2020 | Association of Anaesthetists
National

Recent iatroX Q&As

  • What are the key clinical signs and symptoms that indicate a patient may be experiencing malignant hyperthermia during or after anaesthesia?Updated: 8/16/2025
  • How should I manage a patient suspected of having malignant hyperthermia in a primary care setting before they are referred to a specialist?Updated: 8/16/2025
  • What specific investigations should be conducted to confirm a diagnosis of malignant hyperthermia in a patient presenting with hyperthermia and muscleUpdated: 8/16/2025
  • Which patients with a family history of malignant hyperthermia should be referred for genetic counselling or further evaluation?Updated: 8/16/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play